Author:
Martins-de-Barros Allan Vinícius,da Costa Araújo Fábio Andrey,Faro Tatiane Fonseca,de Aquino Arthur Alves Thomaz,Barbosa Neto Adauto Gomes,da Silva Helker Albuquerque Macedo,de Lima Elker Lene Santos,Muniz Maria Tereza Cartaxo,de Oliveira e Silva Emanuel Dias,de Vasconcelos Carvalho Marianne
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. WHO Classification of Tumours Editorial Board (2022) Head and neck tumours. Lyon (France): International Agency for Research on Cancer. https://publications.iarc.fr/. Accessed 20 Dec 2023
2. Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO (2018) Ameloblastoma: current etiopathological concepts and management. Oral Dis 24(3):307–316. https://doi.org/10.1111/odi.12646
3. McClary AC, West RB, McClary AC, Pollack JR, Fischbein NJ, Holsinger CF, Sunwoo J, Colevas AD, Sirjani D (2016) Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol 273(7):1649–1661. https://doi.org/10.1007/s00405-015-3631-8
4. Martins-de-Barros AV, Silva CCG, Gonçalves KKN, Almeida RAC, Silva EDO, Araújo FAC, Robinson L, van Heerden WFP, Carvalho MV (2023) Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta-analysis. J Oral Pathol Med 52(8):701–709. https://doi.org/10.1111/jop.13458
5. Kurppa KJ, Catón J, Morganv PR, Ristimäki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K (2014) High frequency of BRAF V600E mutations in ameloblastoma. J Pathol 232(5):492–498. https://doi.org/10.1002/path.4317